Abbott NJ, Patabendige AAK, Dolman DEM, Yusof SR, Begley DJ. 2010. Structure and function of the blood-brain barrier. Neurobiol Dis, 37: 13–25.
Alonso A, Marsal S, JuliÃ A. 2015. Analytical methods in untargeted metabolomics: state of the art in 2015. Front Bioeng Biotechnol, 3: 23.
Ambriz-Perez DL, Leyva-Lopez N, Gutierrez-Grijalva EP, Heredia JB. 2016. Phenolic compounds: natural alternative in inflammation treatment. A review. Cogent Food Agric, 2: 1131412.
Ahmad Azam A, Pariyani R, Ismail IS, Ismail A, Khatib A, Abas F, Shaari K. 2017. Urinary metabolomics study on the protective role of Orthosiphon stamineus in Streptozotocin induced diabetes mellitus in rats via 1H NMR spectroscopy. BMC Complement AlternMed, 17: 1–13.
Bélanger M, Allaman I, Magistretti PJ. 2011. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab, 14: 724–738.
Bixel M, Shimomura Y, Hutson S, Hamprecht B. 2001. Distribution of key enzymes of branched-chain amino acid metabolism in glial and neuronal cells in culture. J Histochem Cytochem, 49: 407–418.
Bouzier K, Thiaudiere E, Biran M, Rouland R, Canioni P, Merle M. 2000. The metabolism of [3-(13) C] lactate in the rat brain is specific of a pyruvate carboxylase-deprived compartment. J Neurochem, 75: 480–486.
Bradford J, Shin JY, Roberts M, Wang CE, Li XJ, Li S. 2009. Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc Natl Acad Sci USA, 106: 22480–22485.
Chang L, Munsaka SM, Kraft-Terry S, Ernst T. 2013. Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain. J Neuroimmune Pharmacol, 8: 576–593.
Chen L, Zhang B, Shan S, Zhao X. 2016. Neuroprotective effects of vitexin against isoflurane-induced neurotoxicity by targeting the TRPV1 and NR2B signaling pathways. Mol Med Rep, 14: 5607–5613.
Crandall EA and Fernstrom JD. 1983. Effect of experimental diabetes on the levels of aromatic and branched-chain amino acids in rat blood and brain. Diabetes, 32: 222–230.
De Luca C, Olefsky JMI. 2008. Inflammation and insulin resistance. FEBS Lett, 582: 97–105.
Echeverria V, Zeitlin R. 2012. Cotinine: a potential new therapeutic agent against Alzheimer’s disease. CNS Neurosci Ther, 18: 517–523.
El-Ansary A, Al-Ayadhi L. 2014. GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders. J Neuroinflammation, 11: 189-194.
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). 2001. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285: 2486–2497.
Fernstrom JD. 2005. Branched-chain amino acids and brain function, J Nutr, 135: 1539S–1546S.
Fünfschilling U, Supplie LM., Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann B G, Kassmann CM, Tzvetanova ID, Möbius W, Diaz F, Meijer D, Suter U, Hamprecht B, Sereda MW, Moraes CT, Frahm J, Goebbels S, Nave K. 2012. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature, 485: 517–521.
Gasior M, Rogawski MA, Hartman AL. 2006. Neuroprotective and disease-modifying effects of the ketogenic diet. Behav Pharmacol, 17: 431–439.
Gellért L, Varga DP. 2016. Locomotion activity measurement in an open field for mice. Bio Protoc, 6: 2–6.
Global-disease-burden health grove.com. 2017. Neurological Disorders in Malaysia- Statistics on neurological disorders effect and annual mortality rates from 1990 to 2013. Available at: http://global-disease-burden.healthgrove.com/l/54726/Neurological-Disorders-in-Malaysia. (Accessed 12 April 2017).
Goucham AY, Nicolaïdis S. 1999. Feeding enhances extracellular lactate of local origin in the rostromedial hypothalamus but not in the cerebellum. Brain Res, 816: 84–91.
Guzmán M, Blázquez C. 2004. Ketone body synthesis in the brain: possible neuroprotective effects. Prostaglandins Leukot Essent Fat Acids, 70: 287–292.
Hashimoto T, Hussien R, Cho HS, Kaufer D, Brooks GA. 2008. Evidence for the mitochondrial lactate oxidation complex in rat neurons: demonstration of an essential component of brain lactate shuttles. PLoS One, 3; e2915.
Hemmerle AM, Herman JP, Seroogy KB. 2012. Stress, depression and Parkinson’s disease. Exp Neurol, 233: 79–86.
Hinzman JM, Thomas TC, Quintero JE, Gerhardt GA, Lifshitz J. 2012. Disruptions in the regulation of extracellular glutamate by neurons and glia in the rat striatum two days after diffuse brain injury. J Neurotrauma, 29: 1197–1208.
Jonckheere AI, Smeitink JAM, Rodenburg RJT. 2012. Mitochondrial ATP synthase: architecture, function and pathology. J Inherit Metab Dis, 35: 211–225.
Khoo LW, Mediani A, Zolkeflee NKZ, Leong SW, Ismail IS, Khatib A, Shaari K, Abas F. 2015. Phytochemical diversity of Clinacanthus nutans extracts and their bioactivity correlations elucidated by NMR based metabolomics. Phytochem Lett, 14: 123–133.
Kim E, Jung YS, Kim H, Kim JS, Park M, Jeong J, Lee SK, Yoon HG, Hwang GS, Namkoong K. 2014. Metabolomic signatures in peripheral blood associated with Alzheimer’s disease amyloid-β-induced neuroinflammation. J Alzheimer’s Dis, 42: 421–433.
Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM. 2007. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent Ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther, 321: 892–901.
Kongkaew C, Chaiyakunapruk N. 2011. Efficacy of Clinacanthus nutans extracts in patients with herpes infection: Systematic review and meta-analysis of randomised clinical trials. Complement Ther Med 19: 47–53.
Kunsorn P, Ruangrungsi N, Lipipun V, Khanboon A, Rungsihirunrat K. 2013. The identities and anti-herpes simplex virus activity of Clinacanthus nutans and Clinacanthus siamensis. Asian Pac J Trop Biomed, 3: 284–290.
Kuwabara T, Watanabe H, Tsuji S, Yuasa T. 1995. Lactate rise in the basal ganglia accompanying finger movements: a localized 1H-MRS study. Brain Res, 670: 326–328.
Lau KW, Lee SK, Chin JH. 2014. Effect of the methanol leaves extract of Clinacanthus nutans on the activity of acetylcholinesterase in male mice. J Acute Dis, 3: 22–25.
Laura C. 2011. Fundamentals of inflammation, Yale J Biol Med, 84: 64-65.
Le Guennec A, Tayyari F, Edison AS. 2017. Alternatives to nuclear overhauser enhancement spectroscopy presat and carr-purcell-meiboom-gill presat for NMR-based metabolomics. Anal Chem, 89: 8582–8588.
Le CF, Kailaivasan TH, Chow SC, Abdullah Z, Ling SK, Fang CM. 2017. Phytosterols isolated from Clinacanthus nutans induce immunosuppressive activity in murine cells. Int Immunopharmacol, 44: 203–210.
Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, Liu Y, Tsingalia A, Jin L, Zhang P, Pellerin L, Magistretti PJ, Rothstein JD. 2012. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature, 487: 443–448.
López JC. 2003. Neurodegenerative diseases: a promising therapy for SBMA. Nat RevNeurosci, 4: 519–526.
Lull ME, Block and ML. 2010. Microglial activation and chronic neurodegeneration. Neurotherapeutics, 7. 354–365.
Lyman M, Lloyd DG, Ji X, Vizcaychipi MP, Ma D. 2014. Neuroinflammation: the role and consequences. Neurosci Res, 79: 1–12.
Maddock RJ, Buonocore MH. 2011. MR spectroscopic studies of the brain in psychiatric disorders. In: Carter C., Dalley J. (eds) Brain Imaging in Behavioral Neuroscience. Current Topics in Behavioral Neurosciences, pp. 199–251, Berlin, Heidelberg, Springer.
Maragakis NJ, Rothstein JD. 2001. Glutamate transporters in neurologic disease. Arch. Neurol, 58: 365–370.
Metz GA, Jadavji NM, Smith LK. 2005. Modulation of motor function by stress: a novel concept of the effects of stress and corticosterone on behavior. Eur J Neurosci, 22: 1190–1200.
Milatovic D, Zaja-Milatovic S, Montine KS, Horner PJ, Montine TJ. 2003. Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum. J Neurochem, 87: 1518–1526.
Murín R, Schaer A, Kowtharapu BS, Verleysdonk S, Hamprecht B. 2008. Expression of 3-hydroxyisobutyrate dehydrogenase in cultured neural cells. J Neurochem, 105: 1176–1186.
Norouzi F, Abareshi A, Anaeigoudari A, Shafei NM, Gholamnezhad Z, Saeedjalali M, Mohebbati R, Hosseini M. 2016. The effects of Nigella sativa on sickness behavior induced by lipopolysaccharide in male Wistar rats. Avicenna J Phytomed, 6: 104-116.
Petroff OAC. 2002. GABA and glutamate in the human brain. Neuroscientist, 8: 562–573.
Purkayastha S, Cai D. 2013. Neuroinflammatory basis of metabolic syndrome. Mol Metab, 2: 356–363.
Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT. 2007. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia, 55: 453–462.
Reisenauer CJ, Bhatt DP, Mitteness DJ, Slanczka ER, Gienger HM, Watt JA, Rosenberger TA. 2011. Acetate supplementation attenuates lipopolysaccharide-induced neuroinflammation. J Neurochem, 117: 264–274.
Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, Lokensgard JR, Phillip K, Peterson PK. 2004. Role of microglia in central nervous system infections role. Clin Microbiol Rev, 17: 942–964.
Sakdarat S, Shuyprom A, Pientong C, Ekalaksananan T, Thongchai S. 2009. Bioactive constituents from the leaves of Clinacanthus nutans Lindau. Bioorganic Med Chem, 17: 1857–1860.
Schurr A, Payne RS. 2007. Lactate, not pyruvate, is neuronal aerobic glycolysis end product: an in vitro electrophysiological study. Neuroscience, 147: 613–619.
Scott A, Khan KM, Cook JL, Duronio V. 2004. What is “inflammation”? Are we ready to move beyond Celsus? Br J Sports Med, 38: 248–249.
Sengupta A, Ficker AM, Dunn SK, Madhu M, Cancelas JA. 2012. Bmi1 reprograms CMLB-lymphoid progenitors to become B-ALL-initiating cells. Blood, 119: 494–502.
Sethi S, Brietzke E. 2015. Omics-Based Biomarkers: application of metabolomics in neuropsychiatric disorders. Int J Neuropsychopharmacol, 19: 1-13.
Sleiman SF, Henry J, Al-Haddad R, El Hayek L, Abou Haidar E, Stringer T, Ulja D, Karuppagounder SS, Holson EB, Ratan RR, Ninan I, Chao MV. 2016. Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β- hydroxybutyrate. Elife, 5; e15092.
Solaini G, Baracca A, Lenaz G, Sgarbi G. 2010. Hypoxia and mitochondrial oxidative metabolism. Biochim Biophys Acta, 1797: 1171–1177.
Sookmai W, Ekalaksananan T, Pientong C, Sakdarat S, Kongyingyoes B. 2011. The anti-papillomavirus infectivity of Clinacanthus nutans compounds. Srinagarind Med J, 26: 240–243.
Sun ZK, Yang HQ, Chen SD. 2013. Traditional chinese medicine: a promising candidate for the treatment of Alzheimer’s disease. Transl Neurodegener, 2: 6.
Tijani AY, Salawu OA, Jaiyeoba G-l, Anuka JA, Hussaini IM. 2012. Neuro-pharmacological effects of Crinum zeylanicum in mice. Avicenna J Phytomed, 2: 162-168.
Tuntiwachwuttikul P, Pootaeng-On Y, Phansa P, Taylor WC. 2004. Cerebrosides and a monoacylmonogalactosylglycerol from Clinacanthus nutans. Chem Pharm Bull (Tokyo), 52: 27–32.
Vibulsreth S, Hefti F, Ginsberg MD, Dietrich WD, Busto R. 1987. Astrocytes protect cultured neurons from degeneration induced by anoxia. Brain Res, 422: 303–311.
Walz W, Mukerji S. 1988. Lactate production and release in cultured astrocytes. Neurosci Lett, 86: 296–300.
Wold S. 2001. Personal memories of the early PLS development. Chemom Intell Lab Syst, 58: 83–84.
World Health Organization (WHO) Dept. of Mental Health and Substance Abuse. 2006. Neurological disorders: a public health approach.19; 27- 40.
Xia J, Sinelnikov IV, Han B, Wishart DS. 2015. MetaboAnalyst 3.0- making metabolomics more meaningful. Nucleic Acids Res, 43: 251-257.
Yahaya TA, Okhale SE, Adeola SO. 2013. Neuropharmacological effects of standardized aqueous stem bark extract of Parkia biglobossa in Wistar rats. Avicenna J Phytomed, 4: 59-71.